Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Docetaxel
×
Clear all
Filters
3
NCT04428151
2025-12-04
LEAP-009
Merck Sharp & Dohme LLC
Phase 2
Completed
408 enrolled
17 charts
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled